“keeping a close watch on capital allocation”
= STOP ASKING ABOUT THE BUYBACK YOU DUMMIES
In all seriousness, we need to run trials within BC, large patient populations, possibly a few sites, here & in the US.
Nice if a partner funds but id bet they are planning for the worst by doing it themselves, why else would he assemble such a team…
Retail are pretty clearly tapped out and don’t really want to see another SPP or have to cough up to support another strategy change, despite it being warranted and needed.
My guess is Damo is working hard behind the scenes in preparation for later this year. Hopefully they at least get the SP higher to save dilution
Ann: Letter to Shareholders, page-62
-
- There are more pages in this discussion • 34 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.94 |
Change
0.055(2.92%) |
Mkt cap ! $330.4M | |||
| Open | High | Low | Value | Volume |
| $1.89 | $1.96 | $1.85 | $333.0K | 174.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3105 | $1.94 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.95 | 7574 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |